Publications

Show 1 to 10 of 162 results

Footer

Operated by

University of Münster
Division 6.4: Research Information Management
Department 6: Research Affairs
Domplatz 6-7 | 48143 Münster
cris@uni-muenster.de

Top-Links

About the University of Münster
Research profile of the University of Münster
CRIS-Login

living.knowledge

Legal Disclosure | Privacy Statement | Accessibility

Klotz, Luisa Hildegard

Show 1 to 10 of 162 results

Trajectories of affective disorders: neurobiological mechanisms during symptom change. Ebner-Priemer UW; Alferink J; Bauer M; Dannlowski U; Falkenberg I; Forstner AJ; Hahn T; Junghöfer M; Kircher T; Klotz L; Martini J; Mennigen E; Nenadić I; Pariante C; Pfennig A; Ziller M; Meinert S (2026) In: Der Nervenarzt, 97(2), 138-146. doi:10.1007/s00115-025-01917-4 Review article (journal) \| Peer reviewed \| Published
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis Klotz L, Smolders J, Lehto J, Matilainen M, Lütje L, Buchholz L, Albrecht S, Walter C, Varghese J, Wiendl H, Nylund M, Thomas C, Gardberg M, van den Bosch AMR, Airas L, Huitinga I & Kuhlmann T* (2025) In: Nature Medicine, 31(6), 2016-2026. doi:10.1038/s41591-025-03625-7 Research article (journal) \| Peer reviewed \| Published
Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab Revie L, Jürjens A, Eveslage M, Trümpelmann S, Teschner V, Schulte-Mecklenbeck A, Gross CC, Lünemann JD, Grosch J, Korsukewitz C, Wiendl H, Klotz L. (2025) In: Multiple Sclerosis, 31(7), 813-820. doi:10.1177/13524585251329849 Research article (journal) \| Peer reviewed \| Published
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation Schneider-Hohendorf T, Wünsch C, Falk S, Raposo C, Rubelt F, Mirebrahim H, Asgharian H, Schlecht U, Mattox D, Zhou W, Dawin E, Pawlitzki M, Lauks S, Jarius S, Wildemann B, Havla J, Kümpfel T, Schrot MC, Ringelstein M, Kraemer M, Schwake C, Schmitter T, Ayzenberg I, Fischer K, Meuth SG, Aktas O, Hümmert MW, Kretschmer JR, Trebst C, Kleffner I, Massey J, Muraro PA, Chen-Harris H, Gross CC, Klotz L, Wiendl H, Schwab N. (2025) In: Brain, 148(3), 933-940. doi:10.1093/brain/awae244 Research article (journal) \| Peer reviewed \| Published
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Konen FF; Möhn N; Witte T; Schefzyk M; Wiestler M; Lovric S; Hufendiek K; Jendretzky KF; Gingele S; Schwenkenbecher P; Sühs KW; Friese MA; Klotz L; Pul R; Pawlitzki M; Hagin D; Kleinschnitz C; Meuth SG; Skripuletz T (2025) In: Autoimmunity Reviews, 24(4), 103754-103754. doi:10.1016/j.autrev.2025.103754 Review article (journal) \| Peer reviewed \| Published
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis. In: , -. \| Peer reviewed
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment In: , . \| Peer reviewed
Dietary habits in patients with relapsing-remitting multiple sclerosis and their correlation with clinical signatures of disease activity In: . \| Peer reviewed
Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy In: , . \| Peer reviewed
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort. In: , -. \| Peer reviewed

Konen FF; Witte T; Ernst D; Hagin D; Jendretzky KF; Möhn N; Nay S; Grote-Levi L; Sühs KW; Klotz L; Pfeuffer S; Pul R; Kleinschnitz C; Pawlitzki M; Meuth SG; Skripuletz T

(2025)

Neurological research and practice

, 7

(1)

doi:10.1186/s42466-025-00414-y

Review article (journal)

| Published

Lu, I; Heming, M; Cheung, P; Thomas, C; Dag, M; Giglio, G; Schroeter, C; Nelke, C; Wirth, T; König, S; Siveke, J; Klotz, L; Leo, M; Wiendl, H; Hagenacker, T; Meyer zu Hörste, G

(2024)

Nature Communications

, 15

4120

doi:10.1038/s41467-024-48195-3

Research article (journal)

| Published

Passlick, Johanna; Fleck, Ann-Katrin; Lauks, Sarah; Eveslage, Maria; Bergh, Florian Then; Kuempfel, Tania; Bittner, Stefan; Zipp, Frauke; Wiendl, Heinz; Klotz, Luisa

(2024)

Multiple Sclerosis

, 29

Research article (journal)

| Published

Deffner M, Schneider-Hohendorf T, Schulte-Mecklenbeck A, Falk S, Lu IN, Ostkamp P, Müller-Miny L, Schumann EM, Goelz S, Cahir-McFarland E, Thakur KT, De Jager PL, Klotz L, Meyer Zu Hörste G, Gross CC, Wiendl H, Grauer OM, Schwab N.

(2024)

Cell reports. Medicine

, 5

(7)

101622

doi:10.1016/j.xcrm.2024.101622

Research article (journal)

| Published

Ringelstein M; Asseyer S; Lindenblatt G; Fischer K; Pul R; Skuljec J; Revie L; Giglhuber K; Häußler V; Karenfort M; Hellwig K; Paul F; Bellmann-Strobl J; Otto C; Ruprecht K; Ziemssen T; Emmer A; Rothhammer V; Nickel FT; Angstwurm K; Linker R; Laurent SA; Warnke C; Jarius S; Korporal-Kuhnke M; Wildemann B; Wolff S; Seipelt M; Yalachkov Y; Retzlaff N; Zettl UK; Rommer PS; Kowarik MC; Wickel J; Geis C; Hümmert MW; Trebst C; Senel M; Gold R; Klotz L; Kleinschnitz C; Meuth SG; Aktas O; Berthele A; Ayzenberg I; German Neuromyelitis Optica Study Group (NEMOS)

(2024)

Neurology

, 103

(9)

e209888

doi:10.1212/WNL.0000000000209888

Research article (journal)

| Published

Trajectories of affective disorders: neurobiological mechanisms during symptom change. Ebner-Priemer UW; Alferink J; Bauer M; Dannlowski U; Falkenberg I; Forstner AJ; Hahn T; Junghöfer M; Kircher T; Klotz L; Martini J; Mennigen E; Nenadić I; Pariante C; Pfennig A; Ziller M; Meinert S (2026) In: Der Nervenarzt, 97(2), 138-146. doi:10.1007/s00115-025-01917-4 Review article (journal) \| Peer reviewed \| Published
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis Klotz L, Smolders J, Lehto J, Matilainen M, Lütje L, Buchholz L, Albrecht S, Walter C, Varghese J, Wiendl H, Nylund M, Thomas C, Gardberg M, van den Bosch AMR, Airas L, Huitinga I & Kuhlmann T* (2025) In: Nature Medicine, 31(6), 2016-2026. doi:10.1038/s41591-025-03625-7 Research article (journal) \| Peer reviewed \| Published
Suboptimal B-cell depletion is associated with progression independent of relapse activity in multiple sclerosis patients treated with ocrelizumab Revie L, Jürjens A, Eveslage M, Trümpelmann S, Teschner V, Schulte-Mecklenbeck A, Gross CC, Lünemann JD, Grosch J, Korsukewitz C, Wiendl H, Klotz L. (2025) In: Multiple Sclerosis, 31(7), 813-820. doi:10.1177/13524585251329849 Research article (journal) \| Peer reviewed \| Published
Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation Schneider-Hohendorf T, Wünsch C, Falk S, Raposo C, Rubelt F, Mirebrahim H, Asgharian H, Schlecht U, Mattox D, Zhou W, Dawin E, Pawlitzki M, Lauks S, Jarius S, Wildemann B, Havla J, Kümpfel T, Schrot MC, Ringelstein M, Kraemer M, Schwake C, Schmitter T, Ayzenberg I, Fischer K, Meuth SG, Aktas O, Hümmert MW, Kretschmer JR, Trebst C, Kleffner I, Massey J, Muraro PA, Chen-Harris H, Gross CC, Klotz L, Wiendl H, Schwab N. (2025) In: Brain, 148(3), 933-940. doi:10.1093/brain/awae244 Research article (journal) \| Peer reviewed \| Published
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders. Konen FF; Möhn N; Witte T; Schefzyk M; Wiestler M; Lovric S; Hufendiek K; Jendretzky KF; Gingele S; Schwenkenbecher P; Sühs KW; Friese MA; Klotz L; Pul R; Pawlitzki M; Hagin D; Kleinschnitz C; Meuth SG; Skripuletz T (2025) In: Autoimmunity Reviews, 24(4), 103754-103754. doi:10.1016/j.autrev.2025.103754 Review article (journal) \| Peer reviewed \| Published
Management of disease-modifying therapies in multiple sclerosis and comorbid rheumatoid arthritis. In: , -. \| Peer reviewed
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatment In: , . \| Peer reviewed
Dietary habits in patients with relapsing-remitting multiple sclerosis and their correlation with clinical signatures of disease activity In: . \| Peer reviewed
Chemokine-mediated cell migration into the central nervous system in progressive multifocal leukoencephalopathy In: , . \| Peer reviewed
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders: Routine Clinical Care Data From a European Cohort. In: , -. \| Peer reviewed